Oliver Gaemperli

Showing 1-5 of 5 articles

Interventions for valvular disease

Impact of mitral regurgitation aetiology on MitraClip outcomes: the MitraSwiss registry

Sürder D, Klersy C, Corti R, Biasco L, Gaemperli O, Maisano F, Toggweiler S, Jeger R, Naegeli B, Noble S, Biaggi P, Moccetti T, Pedrazzini G

June 12, 2020 | 10.4244/EIJ-D-19-00718

Interventions for valvular disease

First-in-man report of residual “intra-clip” regurgitation between two MitraClips treated by AMPLATZER Vascular Plug II

Taramasso M, Zuber M, Gruner C, Gaemperli O, Nietlispach F, Maisano F

April 20, 2016 | 10.4244/EIJY14M12_04

Interventions for valvular disease

Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation

Frangieh A, Gruner C, Mikulicic F, Attinger-Toller A, Tanner F, Taramasso M, Corti R, Grünenfelder J, Lüscher T, Ruschitzka F, Bettex D, Maisano F, Gaemperli O

April 8, 2016 | 10.4244/EIJV11I14A320

Successful first-in-man Melody transcatheter valve implant in a dehisced mitral annuloplasty ring transapical valve-in-ring implant

Maisano F, Reser D, Pavicevic J, Nietlispach F, Gaemperli O, Schmid M, Bettex D, Falk V

December 22, 2014 | 10.4244/EIJV10I8A163

Integrated x-ray and echocardiography imaging for structural heart interventions

Corti R, Biaggi P, Gaemperli O, Bühler I, Felix C, Bettex D, Kretschmar O, Falk V, Grünenfelder J

November 29, 2013 | 10.4244/EIJV9I7A140

1

Latest news

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

My Stroke Story

October 20, 2021

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Valvular disease